NCT04281576 2024-11-14
Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma
NovoCure Ltd.
Phase NA Completed
Clinical Trials
14 trialsNCT02569723 2021-03-30
Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy
University of California, Davis
Phase NA Completed
NCT01295086 2020-11-02
Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer
Odense University Hospital
Phase NA Completed
NCT00846482 2020-09-16
Exploratory Study Of The ERCC-1 Gene
Albert Einstein College of Medicine
Phase NA Completed
NCT03121807 2019-06-21
Home Parenteral Nutrition for Malnourished Unresectable Stage IV Gastric Cancer
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Completed
NCT03213444 2019-02-15
Impact of Adjuvant Chemotherapy in Patients With Colon Cancer
University of Sao Paulo General Hospital
Phase NA Completed
NCT01834014 2017-08-02
ATOM ES
EPS Corporation
Phase NA Completed
NCT00448838 2016-12-15
Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
University of Miami
Phase NA Completed
NCT01364376 2016-08-23
Focus
Zhejiang University
Phase NA Completed
NCT00462501 2016-01-20
Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00039611 2013-06-20
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase NA Completed
NCT00250029 2011-09-27
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
New Mexico Cancer Research Alliance
Phase NA Completed
NCT01366118 2011-06-03
TT
Grupo Hospital de Madrid
Phase NA Completed
NCT00040820 2011-03-07
Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
Roswell Park Cancer Institute
Phase NA Completed